BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22710721)

  • 1. Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells.
    Zhu Y; Zhao T; Itasaka S; Zeng L; Yeom CJ; Hirota K; Suzuki K; Morinibu A; Shinomiya K; Ou G; Yoshimura M; Hiraoka M; Harada H
    Oncogene; 2013 Apr; 32(16):2058-68. PubMed ID: 22710721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions.
    Zeng X; Wan L; Wang Y; Xue J; Yang H; Zhu Y
    Int J Radiat Biol; 2020 Aug; 96(8):1060-1067. PubMed ID: 32412317
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
    Grosso S; Doyen J; Parks SK; Bertero T; Paye A; Cardinaud B; Gounon P; Lacas-Gervais S; Noël A; Pouysségur J; Barbry P; Mazure NM; Mari B
    Cell Death Dis; 2013 Mar; 4(3):e544. PubMed ID: 23492775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.
    Harada H; Inoue M; Itasaka S; Hirota K; Morinibu A; Shinomiya K; Zeng L; Ou G; Zhu Y; Yoshimura M; McKenna WG; Muschel RJ; Hiraoka M
    Nat Commun; 2012 Apr; 3():783. PubMed ID: 22510688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy.
    Harada H; Itasaka S; Zhu Y; Zeng L; Xie X; Morinibu A; Shinomiya K; Hiraoka M
    Br J Cancer; 2009 Mar; 100(5):747-57. PubMed ID: 19223896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.
    Liu J; Zhang J; Wang X; Li Y; Chen Y; Li K; Zhang J; Yao L; Guo G
    Exp Cell Res; 2010 Jul; 316(12):1985-93. PubMed ID: 20206160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
    Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
    Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
    Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
    Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azoreductase-Responsive Metal-Organic Framework-Based Nanodrug for Enhanced Cancer Therapy via Breaking Hypoxia-induced Chemoresistance.
    Huang C; Tan W; Zheng J; Zhu C; Huo J; Yang R
    ACS Appl Mater Interfaces; 2019 Jul; 11(29):25740-25749. PubMed ID: 31251022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-dependent accumulation of hypoxia-inducible factor-1 alpha induces transient cell cycle arrest in porcine trophectoderm cells.
    Jeong W; Jung S; Bazer FW; Kim J
    Theriogenology; 2018 Jul; 115():9-15. PubMed ID: 29698887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
    PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau- and mitochondria-dependent manner.
    Kai S; Tanaka T; Daijo H; Harada H; Kishimoto S; Suzuki K; Takabuchi S; Takenaga K; Fukuda K; Hirota K
    Antioxid Redox Signal; 2012 Feb; 16(3):203-16. PubMed ID: 22004513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells.
    Wen W; Ding J; Sun W; Wu K; Ning B; Gong W; He G; Huang S; Ding X; Yin P; Chen L; Liu Q; Xie W; Wang H
    Cancer Res; 2010 Mar; 70(5):2010-9. PubMed ID: 20179204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
    Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
    Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
    Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
    Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
    Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
    Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance.
    Harada H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i99-i105. PubMed ID: 26983985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.